Matt Brown

Infectious Diseases/Antimicrobial Stewardship Pharmacist & ID PGY2 Residency Director @uabmedicine | #WarEagle | Views my own

[SIDP @SIDPharm]

What’s scarier than a misdiagnosed UTI?

Happy Halloween Stewards & Ghouls! 🎃
#stewardship

[Brad Spellberg @BradSpellberg]

Hence my Antibiotic Stewardship for the 21st Century Lecture: slides

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕🔥Mind blowing!
Among 6.3 million adults admitted to 241 US hospitals
50% of all anti-MRSA & antipseudomonal β-lactam prescribing was for suspected community onset sepsis but only 9.5% of pts treated with broad-spectrum Abx had (+) cx for MRSA,PSA or MDR
https://t.co/lqcuXeIWOW

[ALIDS @ALInfectDis]

Registration is now open for the 4th Annual ALIDS Antimicrobial Stewardship Conference‼️ Sign-up today for #ALIDS2024 🤩🧫💊

📍 The Valley Hotel, Homewood, AL
📆 Saturday, July 20
⏰ 8 AM - 3 PM CST
📚 FREE CE

🔗 https://t.co/XyDuLRqvnk

[Ashley Winter MD || Urologist @AshleyGWinter]

That article annoyed me so much I made a video.
Hi, @BBC if you want help reporting on UTIs in women I am happy to help.

[ALIDS @ALInfectDis]

Dr. Anel Couzo representing @UABPharmRes with her data on “Identifying institution specific risk factors for Pseudomonas aeruginosa & MRSA pneumonia” at #MADID2024

[ALIDS @ALInfectDis]

Mark your calendars for ALIDS Antimicrobial Stewardship Conference 🎉

📆 Saturday, July 20
⏰ 8 AM - 3 PM
📍 Homewood, AL
📚 4 hours of FREE CE

A big thanks to @MAD_ID_ASP for co-promoting this event for us. Be sure to register for their meeting at https://t.co/JGF1KIem79

[Krutika Mediwala Hornback @krutu8]

👏🏽 Very proud of our ID fellow, Dr. Jensie Burton, for presenting her ASP rotation project on S. pneumo Ag and its utility locally and at @SHEA_Epi . Bottom line: 🚮 it, save $$$ 👏🏽

@ID_MUSC @MUSCPharmRes @MUSC_COM @MUSChealth @MUSChealth @RachB_PharmD

[Matt Brown @mlbrownrx]

So excited to continue working with @ID_JD_PharmD next year! Let’s get after it! 🧫🦠💊📉📊

[UAB Hospital Pharmacy Residency @UABPharmRes]

🌟And now a welcome to our Class of PGY2 residents!🌟🌟Beginning with PGY2 Infectious Diseases, our own J.D. Olivet!🎆 @ID_JD_PharmD @UABPharmRes @SamfordPharmacy

[SIDP @SIDPharm]

ASB? Let it be 🙅‍♀️ #SIDP #stewardship #TwitteRx #IDtwitter

[Matt Brown @mlbrownrx]

@ewood_1875 @auhcop It was an honor and a pleasure to speak to these students, and it’s always exciting to visit the loveliest village on the plains! I definitely saw some stewards 👀 and the future looks bright!😎

[Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship]

❤️ Happy Valentines Day #IDtwitter #IDxPosts

Our friends still don’t know what we do
Bless our Gram-stained hearts
PK/PD Queens and Kings
Of all the moving parts

Bugs and drugs and MICs
Negotiating, planting seeds
In vitro wants, in vivo dreams
Grace our Gram-stained hearts

Interactions, ADRs
Combing notes and checking MARs
Delabeling allergies (au revoir!)
Delights the Gram-stained heart

Relearning that which we were taught
Data diving, answers sought
Framing unrequested thoughts
And baring Gram-stained hearts

Working with Doctors, APPs
Nurses and Lab – our Phamily
Case management, Micro, ICP!
Makes strong our Gram-stained hearts

We bring to bear all that we know
Waging wars on tiny foes
To aid a cure, to heal, and so
Sustain our Gram-stained hearts

@ShorterSeddonRx credit 🤓

[InsightRX @InsightRX]

New study concluded use of #ModelInformedPrecisionDosing & single-concentration monitoring improved overall outcomes among patients receiving AUC-guided #vancomycin for culture-proven gram-positive infections compared to trough-guided therapy: https://t.co/fAtTbxWGZN @UABMedicine

[Paul Sax @PaulSaxMD]

Guidelines from @acog continue to recommend amp/gent+/-clinda for intraamniotic infections. This observational study in @CIDJournal strongly suggests that cefoxitin would be just as good -- and maybe better. Time for a guidelines change? @julie_justo https://t.co/EtIGm2bqNd

[SIDP @SIDPharm]

We’re ID Pharmacists, of course we’re going to ask you about those antibiotic allergies 💊 #WeareID

[IDSA @IDSAInfo]

In @OFIDJournal, Nicole Hall, PharmD, and colleagues evaluated the safety and efficacy of AUC-guided vancomycin therapy using MIPD and single-concentration monitoring.

Read: https://t.co/ehsS6BAB2z

[Matt Brown @mlbrownrx]

Honored to be part of the team that helped make all this possible for our patients and institution. Still much work to do to 📉 unnecessary vancomycin use…but improved safety is reassuring, when use is indicated or not. @SEdwardsPharmD @NicoleHPharmD @UABPharmRes @UAB_ID

[Matt Brown @mlbrownrx]

Incredibly proud of ⁦@NicoleHPharmD⁩ for the hard work put into this project! Getting here was a huge team effort, and so many advantages of the vancomycin dosing and monitoring strategy described are becoming more and more evident. 👏👏 https://t.co/mVqf5tWq4v

[Matt Brown @mlbrownrx]

✅ Improved safety (⬇️ AKI)
✅ Prompt, individualized treatment
✅ Throughput (⬇️ ICU/hospital LOS)
✅ Simpler operations (pharmacy, nursing, lab)
✅ Better patient satisfaction (not directly assessed, but >1/3 vanc levels did not require an extra blood draw)